Evidence map›Paper›PMID 28861031›Full record

ReviewFrontiers in neurology2017

Visual Dysfunction in Posterior Cortical Atrophy.

Mari N Maia da Silva, Rebecca S Millington, Holly Bridge, Merle James-Galton, Gordon T Plant

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Diagnosis and Management of Posterior Cortical Atrophy.Current treatment options in neurology · 2023
    Review
  14. Simulation of neuroplasticity in a CNN-basedFrontiers in computational neuroscience · 2023
    Article
  15. Article
  16. Article
  17. Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy.Journal of neuropathology and experimental neurology · 2022
    Article
  18. Modeling NeurodegenerationFrontiers in neuroinformatics · 2021
    Article
  19. Review
  20. Posterior cortical atrophy initially presenting as dementia with Lewy bodies.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Mari N Maia da SilvaThe National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Rebecca S MillingtonOxford Centre for fMRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Holly BridgeOxford Centre for fMRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
Merle James-GaltonThe National Hospital for Neurology and Neurosurgery, London, United Kingdom.
Gordon T PlantThe National Hospital for Neurology and Neurosurgery, London, United Kingdom.
University College London · GBMoorfields Eye Hospital · GBUniversity of Oxford · GBWellcome Centre for Integrative Neuroimaging · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posterior cortical atrophy (PCA) is a syndromic diagnosis. It is characterized by progressive impairment of higher (cortical) visual function with imaging evidence of degeneration affecting the occipital, parietal, and posterior temporal lobes bilaterally. Most cases will prove to have Alzheimer pathology. The aim of this review is to summarize the development of the concept of this disorder since it was first introduced. A critical discussion of the evolving diagnostic criteria is presented and the differential diagnosis with regard to the underlying pathology is reviewed. Emphasis is given to the visual dysfunction that defines the disorder, and the classical deficits, such as simultanagnosia and visual agnosia, as well as the more recently recognized visual field defects, are reviewed, along with the evidence on their neural correlates. The latest developments on the imaging of PCA are summarized, with special attention to its role on the differential diagnosis with related conditions.

Indexed as

Alzheimer’s disease (AD)Balint’s syndromehemianopiamagnetic resonance imaging imagingposterior cortical atrophyvisual agnosiavisual fields

Identifiers

PMID28861031
PMCPMC5561011
OpenAlexW2745947374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.